Table 3.
Factors | Univariate | Multivariatea | ||||
---|---|---|---|---|---|---|
OR | 95 % CI | p value | OR | 95 % CI | p value | |
Age (per 1 year) | 0.97 | 0.95–1.00 | 0.09 | 0.99 | 0.96–1.01 | 0.27 |
Male sex | 0.70 | 0.30–1.81 | 0.51 | |||
Body mass index (per 1 kg/m2) | 1.01 | 0.89–1.14 | 0.87 | |||
Alcohol drinker | 1.19 | 0.49–2.92 | 0.70 | |||
Smoker | 1.93 | 0.49–7.62 | 0.35 | |||
Caffeine intake | 1.02 | 0.45–2.30 | 0.97 | |||
IBD type, CD | 0.65 | 0.21–2.00 | 0.46 | |||
Disease duration (per 1 year) | 1.05 | 0.99–1.11 | 0.11 | 1.04 | 0.99–1.10 | 0.09 |
Active disease | 1.87 | 0.65–5.40 | 0.25 | |||
Prior IBD surgery | 1.21 | 0.60–2.42 | 0.60 | |||
Current medication use | ||||||
Steroids | 0.96 | 0.12–7.80 | 0.97 | |||
5-aminosalicylates | 1.82 | 0.56–5.86 | 0.31 | |||
Immunomodulators | 1.37 | 0.52–3.65 | 0.52 | |||
Anti-TNF biologics | 0.62 | 0.18–2.10 | 0.44 | |||
Sleep medications | 1.75 | 0.46–6.69 | 0.42 | |||
Sleep disturbances | 2.69 | 1.14–6.34 | 0.02 | 3.09 | 1.47–6.43 | <0.01 |
Data are expressed as mean ± SD, or frequency. IBD inflammatory bowel disease, UC ulcerative colitis, CD Crohn’s disease, TNF tumor necrosis factor, OR odds ratio, CI confidence intervals
a Adjusted for age, disease duration, and sleep disturbances